# Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

> **NCT00597753** · PHASE3 · COMPLETED · sponsor: **Affymax** · enrollment: 803 (actual)

## Conditions studied

- Chronic Renal Failure
- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** peginesatide
- **DRUG:** Epoetin Alfa

## Key facts

- **NCT ID:** NCT00597753
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-07
- **Final completion:** 2010-01
- **Target enrollment:** 803 (ACTUAL)
- **Last updated:** 2013-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00597753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00597753, "Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00597753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*